Clinical Research Directory
Browse clinical research sites, groups, and studies.
POTS Adrenergic Ab (CIHR Aims #1&2)
Sponsor: University of Calgary
Summary
Objective: In this pilot study, we will test the hypothesis that patients with POTS (age 18-60 years) will have a higher percentage of functional antibodies to adrenergic receptors compared with control subjects without POTS.
Official title: The Pathophysiological Role of Adrenergic Antibodies in Postural Tachycardia Syndrome (Aims #1&2)
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
OBSERVATIONAL
Enrollment
125
Start Date
2016-01
Completion Date
2027-12
Last Updated
2025-03-25
Healthy Volunteers
Yes
Conditions
Interventions
Phenylephrine
incremental small doses of IV phenylephrine to find the dose that transiently raises systolic blood pressure by 25 mmHg
Isoproterenol
incremental small doses of IV isoproterenol to find the dose that transiently raises heart rate by 25 bpm
Locations (1)
University of Calgary
Calgary, Alberta, Canada